GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.300
-0.070 (-5.11%)
May 13, 2026, 4:00 PM EDT - Market closed
GeoVax Labs Employees
GeoVax Labs had 19 employees as of December 31, 2025. The number of employees increased by 2 or 11.76% compared to the previous year.
Employees
19
Change (1Y)
2
Growth (1Y)
11.76%
Revenue / Employee
$131,008
Profits / Employee
-$1,129,725
Market Cap
3.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 2 | 11.76% | 19 | 0 |
| Dec 31, 2024 | 17 | 0 | - | 17 | 0 |
| Dec 31, 2023 | 17 | 3 | 21.43% | 17 | 0 |
| Dec 31, 2022 | 14 | 3 | 27.27% | 14 | 0 |
| Dec 31, 2021 | 11 | 2 | 22.22% | 11 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
| Galmed Pharmaceuticals | 6 |
| Akari Therapeutics, | 6 |
| Indaptus Therapeutics | 5 |
GOVX News
- 26 days ago - GeoVax Labs price target lowered to $10 from $14 at Roth Capital - TheFly
- 27 days ago - GeoVax Labs files to sell 1.27M shares of common stock for holders - TheFly
- 27 days ago - GeoVax Labs files to sell 865,804 shares of common stock for holders - TheFly
- 2 months ago - GeoVax Labs downgraded to Hold from Buy at D. Boral Capital - TheFly
- 4 months ago - GeoVax Labs Transcript: Biotech Showcase 2026 - Transcripts
- 4 months ago - Geovax Labs Inc trading halted, news pending - TheFly
- 5 months ago - GeoVax Labs files to sell 18.29M units - TheFly
- 6 months ago - GeoVax Labs Earnings Call Transcript: Q3 2025 - Transcripts